Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METFORMIN Cause Interstitial lung disease? 265 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 265 reports of Interstitial lung disease have been filed in association with METFORMIN (Metformin Hydrochloride). This represents 0.3% of all adverse event reports for METFORMIN.

265
Reports of Interstitial lung disease with METFORMIN
0.3%
of all METFORMIN reports
18
Deaths
212
Hospitalizations

How Dangerous Is Interstitial lung disease From METFORMIN?

Of the 265 reports, 18 (6.8%) resulted in death, 212 (80.0%) required hospitalization, and 30 (11.3%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METFORMIN. However, 265 reports have been filed with the FAERS database.

What Other Side Effects Does METFORMIN Cause?

Lactic acidosis (16,316) Acute kidney injury (11,361) Diarrhoea (7,679) Toxicity to various agents (5,669) Metabolic acidosis (5,236) Hypoglycaemia (5,047) Drug ineffective (4,991) Nausea (4,915) Vomiting (4,624) Blood glucose increased (4,038)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which METFORMIN Alternatives Have Lower Interstitial lung disease Risk?

METFORMIN vs METFORMIN\PIOGLITAZONE METFORMIN vs METFORMIN\ROSIGLITAZONE METFORMIN vs METFORMIN\SAXAGLIPTIN METFORMIN vs METFORMIN\SITAGLIPTIN METFORMIN vs METFORMIN\VILDAGLIPTIN

Related Pages

METFORMIN Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease METFORMIN Demographics